Hikma Pharmaceuticals PLC (HIK.L)
GBp 1921.0
(-0.05%)
GBp 1921.0
(-0.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.47 Billion USD | 6.37% |
| 2022 | 2.32 Billion USD | 21.94% |
| 2021 | 1.9 Billion USD | -4.13% |
| 2020 | 1.98 Billion USD | 10.33% |
| 2019 | 1.8 Billion USD | 0.06% |
| 2018 | 1.8 Billion USD | -3.23% |
| 2017 | 1.86 Billion USD | -4.71% |
| 2016 | 1.95 Billion USD | 56.79% |
| 2015 | 1.24 Billion USD | 20.29% |
| 2014 | 1.03 Billion USD | 15.64% |
| 2013 | 895 Million USD | 1.44% |
| 2012 | 882.26 Million USD | 13.55% |
| 2011 | 777 Million USD | 112.58% |
| 2010 | 365.52 Million USD | 7.68% |
| 2009 | 339.46 Million USD | -5.04% |
| 2008 | 357.46 Million USD | -23.84% |
| 2007 | 469.38 Million USD | 238.77% |
| 2006 | 138.55 Million USD | 25.41% |
| 2005 | 110.48 Million USD | 9.06% |
| 2004 | 101.3 Million USD | 76.52% |
| 2003 | 57.39 Million USD | 22.54% |
| 2002 | 46.83 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.54 Billion USD | 0.0% |
| 2023 Q2 | 2.41 Billion USD | 0.0% |
| 2023 FY | 2.47 Billion USD | 6.37% |
| 2023 Q4 | 2.47 Billion USD | 0.0% |
| 2022 Q4 | 2.32 Billion USD | 0.0% |
| 2022 FY | 2.32 Billion USD | 21.94% |
| 2022 Q2 | 2.55 Billion USD | 0.0% |
| 2021 FY | 1.9 Billion USD | -4.13% |
| 2021 Q2 | 1.87 Billion USD | 0.0% |
| 2021 Q4 | 1.9 Billion USD | 0.0% |
| 2020 Q2 | 2.07 Billion USD | 0.0% |
| 2020 FY | 1.98 Billion USD | 10.33% |
| 2020 Q4 | 1.98 Billion USD | 0.0% |
| 2019 Q4 | 1.8 Billion USD | 0.0% |
| 2019 Q2 | 1.76 Billion USD | 0.0% |
| 2019 FY | 1.8 Billion USD | 0.06% |
| 2018 Q2 | 1.8 Billion USD | 0.0% |
| 2018 FY | 1.8 Billion USD | -3.23% |
| 2018 Q4 | 1.8 Billion USD | 0.0% |
| 2017 Q2 | 1.94 Billion USD | 0.0% |
| 2017 FY | 1.86 Billion USD | -4.71% |
| 2017 Q4 | 1.86 Billion USD | 0.0% |
| 2016 Q4 | 1.95 Billion USD | 0.0% |
| 2016 FY | 1.95 Billion USD | 56.79% |
| 2016 Q2 | 2.1 Billion USD | 0.0% |
| 2015 FY | 1.24 Billion USD | 20.29% |
| 2015 Q2 | 1.23 Billion USD | 0.0% |
| 2015 Q4 | 1.24 Billion USD | 0.0% |
| 2014 Q2 | 896 Million USD | 0.0% |
| 2014 Q4 | 1.03 Billion USD | 0.0% |
| 2014 FY | 1.03 Billion USD | 15.64% |
| 2013 Q4 | 895 Million USD | 0.0% |
| 2013 Q2 | 834.91 Million USD | 0.0% |
| 2013 FY | 895 Million USD | 1.44% |
| 2012 Q4 | 882.26 Million USD | 300.0% |
| 2012 Q3 | 220.56 Million USD | -74.82% |
| 2012 Q2 | 875.82 Million USD | 297.08% |
| 2012 Q1 | 220.56 Million USD | -71.61% |
| 2012 FY | 882.26 Million USD | 13.55% |
| 2011 Q1 | 194.25 Million USD | -44.42% |
| 2011 Q3 | 194.25 Million USD | -69.1% |
| 2011 FY | 777 Million USD | 112.58% |
| 2011 Q4 | 777 Million USD | 300.0% |
| 2011 Q2 | 628.56 Million USD | 223.59% |
| 2010 Q4 | 349.52 Million USD | 300.0% |
| 2010 Q2 | 366.04 Million USD | 318.91% |
| 2010 Q1 | 87.38 Million USD | -74.26% |
| 2010 FY | 365.52 Million USD | 7.68% |
| 2010 Q3 | 87.38 Million USD | -76.13% |
| 2009 Q3 | 84.86 Million USD | -76.32% |
| 2009 FY | 339.46 Million USD | -5.04% |
| 2009 Q4 | 339.46 Million USD | 300.0% |
| 2009 Q2 | 358.34 Million USD | 322.25% |
| 2009 Q1 | 84.86 Million USD | -76.26% |
| 2008 Q4 | 357.46 Million USD | 300.0% |
| 2008 Q1 | 89.36 Million USD | -80.96% |
| 2008 Q2 | 359.5 Million USD | 302.28% |
| 2008 Q3 | 89.36 Million USD | -75.14% |
| 2008 FY | 357.46 Million USD | -23.84% |
| 2007 Q4 | 469.38 Million USD | 300.0% |
| 2007 Q1 | 117.34 Million USD | -15.31% |
| 2007 FY | 469.38 Million USD | 238.77% |
| 2007 Q2 | 221.66 Million USD | 88.9% |
| 2007 Q3 | 117.34 Million USD | -47.06% |
| 2006 FY | 138.55 Million USD | 25.41% |
| 2006 Q1 | 34.63 Million USD | -68.65% |
| 2006 Q2 | 104.42 Million USD | 201.47% |
| 2006 Q3 | 34.63 Million USD | -66.83% |
| 2006 Q4 | 138.55 Million USD | 300.0% |
| 2005 Q3 | 27.61 Million USD | -79.03% |
| 2005 Q1 | 27.61 Million USD | 9.06% |
| 2005 FY | 110.48 Million USD | 9.06% |
| 2005 Q4 | 110.47 Million USD | 300.0% |
| 2005 Q2 | 131.71 Million USD | 376.87% |
| 2004 FY | 101.3 Million USD | 76.52% |
| 2004 Q4 | 25.32 Million USD | 0.0% |
| 2004 Q3 | 25.32 Million USD | 0.0% |
| 2004 Q1 | 25.32 Million USD | 76.51% |
| 2004 Q2 | 25.32 Million USD | 0.0% |
| 2003 Q2 | 14.34 Million USD | 0.0% |
| 2003 FY | 57.39 Million USD | 22.54% |
| 2003 Q4 | 14.34 Million USD | 0.0% |
| 2003 Q1 | 14.34 Million USD | 22.54% |
| 2003 Q3 | 14.34 Million USD | 0.0% |
| 2002 Q1 | 11.7 Million USD | 0.0% |
| 2002 Q3 | 11.7 Million USD | 0.0% |
| 2002 Q4 | 11.7 Million USD | 0.0% |
| 2002 Q2 | 11.7 Million USD | 0.0% |
| 2002 FY | 46.83 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|